Get the Stockscreener App
15.60
1.10%
0.1693
Sotera Health Co stock is traded at $15.60, with a volume of 8.85M.
It is up +1.10% in the last 24 hours and up +1.56% over the past month.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
See More
Previous Close:
$15.43
Open:
$15.28
24h Volume:
8.85M
Relative Volume:
2.96
Market Cap:
$4.45B
Revenue:
$1.19B
Net Income/Loss:
$117.80M
P/E Ratio:
49.07
EPS:
0.3179
Net Cash Flow:
$144.80M
1W Performance:
+1.76%
1M Performance:
+1.56%
6M Performance:
-4.00%
1Y Performance:
+15.56%
1-Day Range:
$15.16
$15.64
1-Week Range:
$15.16
$16.17
52-Week Range:
$10.79
$19.85
Sotera Health Co Stock (SHC) Company Profile
Name
Sotera Health Co
Sector
Industry
Phone
440-262-1410
Address
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
15.61 | 4.40B | 1.19B | 117.80M | 144.80M | 0.3179 |
TMO
Thermo Fisher Scientific Inc
|
459.30 | 168.20B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
166.07 | 117.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
540.29 | 41.97B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
350.11 | 34.17B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
112.70 | 31.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-26 | Resumed | RBC Capital Mkts | Outperform |
| Dec-18-25 | Initiated | William Blair | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| May-05-25 | Upgrade | Goldman | Neutral → Buy |
| Dec-06-24 | Initiated | Goldman | Neutral |
| May-21-24 | Initiated | Piper Sandler | Neutral |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Mar-25-24 | Upgrade | Jefferies | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Jun-26-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-23-23 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-11-23 | Upgrade | Barclays | Underweight → Overweight |
| Jan-11-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-15-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-26-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-21-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Sep-20-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-09-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-03-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-14-21 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Citigroup | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | JP Morgan | Overweight |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | RBC Capital Mkts | Outperform |
View All
Sotera Health Co Stock (SHC) Latest News
Sotera Health (SHC) Launches Secondary Share Offering of 31.84 M - GuruFocus
Sotera Health names new CEO in planned leadership transition - MSN
Goldman Sachs Takes Lead in SHC Offering - GuruFocus
Sotera Health (NASDAQ: SHC) Sponsors sell 31.84M shares, rights end - Stock Titan
Sotera Health’s private equity backers launch secondary offering - Investing.com
Sotera Health’s private equity backers launch secondary offering By Investing.com - Investing.com Canada
Sotera Health Announces Secondary Offering of Common Stock - The Manila Times
Press Release: Sotera Health Announces Secondary Offering of Common Stock - Moomoo
Sotera Health Co stock (US8293551086): Q1 2026 profit rebound on 10% revenue growth - AD HOC NEWS
SHC Technical Analysis & Stock Price Forecast - Intellectia AI
MSN Money - MSN
Why Broyhill May Be Buying More Sotera Health Shares - AOL.com
Sotera Health taps medical industry veteran Alton Shader as next CEO - The Business Journals
A Quick Look at Today's Ratings for Sotera Health Company(SHC.US), With a Forecast Between $18 to $26 - Moomoo
Sotera Health Company (NASDAQ:SHC) Q1 2026 Earnings Call Transcript - Insider Monkey
Wolfe Research lowers Sotera Health stock price target to $19 on valuation - Investing.com
Sotera Health Q1 2026 slides: earnings beat amid segment divergence By Investing.com - Investing.com Australia
Sotera Health Q1 Earnings Call Highlights - Yahoo Finance
Sotera Health (SHC) Q1 2026 lifts profit with 10% revenue growth - Stock Titan
Earnings call transcript: Sotera Health Q1 2026 beats forecasts, stock dips By Investing.com - Investing.com South Africa
Sotera Health Momentum Builds Beyond Nasdaq Futures Trends - Kalkine Media
Sotera Health reaffirms 2026 outlook of $1.233B-$1.251B revenue and names Alton Shader CEO effective May 26 - MSN
Sotera Health Company Q1 2026 Earnings Call Summary - Yahoo Finance
Sotera Health announces a new CEO - Crain's Cleveland
Should Sotera Health’s (SHC) Return to Quarterly Profitability Prompt Action From Investors? - simplywall.st
Sotera Health Q1 2026 slides: earnings beat amid segment divergence - Investing.com
Earnings call transcript: Sotera Health Q1 2026 beats forecasts, stock dips - Investing.com UK
Sotera Health Q1 2026 Earnings Call Transcript - Benzinga
Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Q1 2026 Sotera Health Co Earnings Call Transcript - GuruFocus
Sotera Health (NASDAQ:SHC) Surges 4% After Q1 Earnings Beat and Reaffirmed 2026 Outlook - ChartMill
Sotera Health Company’s (NASDAQ:SHC) Q1 CY2026: Beats On Revenue, Stock Soars - Yahoo Finance
Sotera Health names Viant Medical CEO as new chief executive By Investing.com - Investing.com Australia
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook - The Manila Times
Sotera Health names Viant Medical CEO as new chief executive - Investing.com
Sotera Health (NASDAQ: SHC) posts Q1 growth and plans CEO change - Stock Titan
Sotera Health Announces Leadership Transition - The Manila Times
Sotera Health picks Viant Medical CEO Alton Shader as new chief - Stock Titan
Sotera Health Co (SHC) Q1 2026 Earnings Report Preview: What To Expect - GuruFocus
Sotera Health faces earnings test as legal overhang eases By Investing.com - Investing.com Australia
Sotera Health faces earnings test as legal overhang eases - Investing.com UK
Sotera Health Co Stock (SHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):